Repligen Financial Statements From 2010 to 2026

RGEN Stock  USD 165.79  3.26  1.93%   
Repligen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Repligen's valuation are provided below:
Gross Profit
365.2 M
Profit Margin
0.0025
Market Capitalization
9.5 B
Enterprise Value Revenue
13.3581
Revenue
707.9 M
We have found one hundred twenty available trending fundamental ratios for Repligen, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to check out Repligen's recent fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 8th of January 2026, Market Cap is likely to grow to about 13.8 B. Also, Enterprise Value is likely to grow to about 13.5 B

Repligen Total Revenue

766.04 Million

Check Repligen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Repligen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 104.5 M, Interest Expense of 21.3 M or Total Revenue of 766 M, as well as many indicators such as Price To Sales Ratio of 10.05, Dividend Yield of 0.0 or PTB Ratio of 2.9. Repligen financial statements analysis is a perfect complement when working with Repligen Valuation or Volatility modules.
  
Build AI portfolio with Repligen Stock
Check out the analysis of Repligen Correlation against competitors.
To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

Repligen Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Short and Long Term Debt Total828.6 M789.2 M301.1 M
Slightly volatile
Other Current Liabilities80.1 M76.3 M31.5 M
Slightly volatile
Total Current Liabilities153.1 M145.8 M115.7 M
Slightly volatile
Property Plant And Equipment Net402.2 M383.1 M134.2 M
Slightly volatile
Cash914.5 M871 M376.4 M
Slightly volatile
Non Current Assets Total2.1 BB802.6 M
Slightly volatile
Non Currrent Assets Other742.1 K781.2 K962.8 K
Very volatile
Cash And Short Term Investments914.5 M871 M385.1 M
Slightly volatile
Net Receivables161.9 M154.2 M62 M
Slightly volatile
Common Stock Shares Outstanding67.5 M64.3 M43.8 M
Slightly volatile
Liabilities And Stockholders Equity3.4 B3.3 B1.3 B
Slightly volatile
Non Current Liabilities Total881.7 M839.7 M248.1 M
Slightly volatile
Inventory172.6 M164.4 M84 M
Slightly volatile
Other Current Assets38.2 M36.3 M13.8 M
Slightly volatile
Other Stockholder EquityB1.9 B879.1 M
Slightly volatile
Total LiabilitiesB985.5 M363.8 M
Slightly volatile
Property Plant And Equipment Gross598.4 M569.9 M183.5 M
Slightly volatile
Total Current Assets1.3 B1.2 B544.6 M
Slightly volatile
Accounts Payable38.8 M37 M15.6 M
Slightly volatile
Short Term Debt16.5 M17.4 M100.5 M
Very volatile
Intangible Assets480.5 M457.6 M193.7 M
Slightly volatile
Common Stock Total Equity389.2 K639.4 K434.3 K
Slightly volatile
Common Stock408 K645.1 K436.6 K
Slightly volatile
Property Plant Equipment230.2 M219.3 M82 M
Slightly volatile
Other Liabilities94.6 M90.1 M40.6 M
Slightly volatile
Current Deferred Revenue16 M15.2 M6.7 M
Slightly volatile
Good Will1.2 B1.2 B528.8 M
Slightly volatile
Net Tangible Assets847.1 M806.7 M387.8 M
Slightly volatile
Capital Surpluse1.9 B1.8 B885.4 M
Slightly volatile
Non Current Liabilities Other41.4 M41.7 M36 M
Slightly volatile
Deferred Long Term Asset Charges2.2 M2.9 M2.5 M
Pretty Stable
Long Term Debt Total156.7 M267.7 M165.9 M
Slightly volatile
Short and Long Term Debt75.9 M79.9 M128.9 M
Pretty Stable
Net Invested Capital1.9 B2.9 B1.4 B
Slightly volatile
Net Working Capital630.1 M1.1 B459.8 M
Slightly volatile
Capital Stock587.1 K645.1 K498.8 K
Slightly volatile
Capital Lease Obligations110.8 M184.8 M69.1 M
Slightly volatile

Repligen Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization104.5 M99.5 M107.3 M
Pretty Stable
Total Revenue766 M729.6 M1.7 B
Slightly volatile
Gross Profit532 M315.8 M1.2 B
Slightly volatile
Other Operating Expenses960.1 M770 M2.1 B
Slightly volatile
Cost Of Revenue234.1 M413.8 M534.2 M
Slightly volatile
Total Operating Expenses338.4 M356.2 M1.6 B
Slightly volatile
Research Development47.2 M49.7 M579.6 M
Slightly volatile
Selling General Administrative347.8 M237 M644.2 M
Slightly volatile
Net Income Applicable To Common Shares224.5 M213.9 M78 M
Slightly volatile
Interest IncomeM4.6 M2.8 M
Slightly volatile
Reconciled Depreciation104.5 M99.5 M34.9 M
Slightly volatile
Extraordinary Items7.7 M8.6 M9.4 M
Slightly volatile
Selling And Marketing Expenses504.8 K567.9 K619.9 K
Slightly volatile

Repligen Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow907.2 M864 M329 M
Slightly volatile
Depreciation104.5 M99.5 M32.4 M
Slightly volatile
Capital Expenditures30.5 M37.8 M59.3 M
Pretty Stable
End Period Cash Flow914.5 M871 M374 M
Slightly volatile
Stock Based Compensation49.8 M43.3 M17.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.0511.4211.9003
Slightly volatile
PTB Ratio2.93.674.4543
Pretty Stable
Days Sales Outstanding46.569.4462.6055
Pretty Stable
Average Payables2.6 M2.5 M2.5 M
Slightly volatile
Stock Based Compensation To Revenue0.08280.08710.2427
Slightly volatile
Capex To Depreciation0.420.440.9238
Very volatile
PB Ratio2.93.674.4543
Pretty Stable
EV To Sales8.9811.3211.2814
Slightly volatile
Inventory Turnover3.232.892.8898
Slightly volatile
Days Of Inventory On Hand134131169
Slightly volatile
Payables Turnover10.5810.0811.4218
Pretty Stable
Sales General And Administrative To Revenue0.370.390.318
Slightly volatile
Average Inventory14.4 M13.7 M12.8 M
Slightly volatile
Research And Ddevelopement To Revenue0.07440.07830.1864
Slightly volatile
Capex To Revenue0.09580.05960.072
Pretty Stable
Cash Per Share12.7912.197.2224
Slightly volatile
Days Payables Outstanding35.6137.4936.3436
Very volatile
Current Ratio9.479.676.8221
Very volatile
Receivables Turnover10.05.445.9859
Pretty Stable
Shareholders Equity Per Share33.3331.7418.2595
Slightly volatile
Debt To Equity0.330.310.3495
Slightly volatile
Capex Per Share0.560.530.4854
Slightly volatile
Graham Net Net1.341.172.4022
Pretty Stable
Average Receivables8.1 M7.7 M8.1 M
Slightly volatile
Revenue Per Share10.7210.216.2318
Slightly volatile
Interest Debt Per Share11.9711.44.8811
Slightly volatile
Debt To Assets0.180.220.3008
Pretty Stable
Graham Number11.1820.2615.9637
Slightly volatile
Operating Cycle154200230
Slightly volatile
Price Book Value Ratio2.93.674.4543
Pretty Stable
Days Of Payables Outstanding35.6137.4936.3436
Very volatile
Ebt Per Ebit1.020.890.8726
Pretty Stable
Long Term Debt To Capitalization0.20.190.2411
Slightly volatile
Total Debt To Capitalization0.240.230.2448
Pretty Stable
Debt Equity Ratio0.330.310.3495
Slightly volatile
Quick Ratio8.58.376.1924
Pretty Stable
Net Income Per E B T1.171.091.0971
Very volatile
Cash Ratio5.846.874.6712
Very volatile
Cash Conversion Cycle222218204
Slightly volatile
Days Of Inventory Outstanding134131169
Slightly volatile
Days Of Sales Outstanding46.569.4462.6055
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.130.930.7307
Pretty Stable
Price To Book Ratio2.93.674.4543
Pretty Stable
Fixed Asset Turnover1.631.714.1344
Slightly volatile
Debt Ratio0.180.220.3008
Pretty Stable
Price Sales Ratio10.0511.4211.9003
Slightly volatile
Gross Profit Margin0.680.50.5325
Pretty Stable
Price Fair Value2.93.674.4543
Pretty Stable

Repligen Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap13.8 B13.1 B9.4 B
Slightly volatile
Enterprise Value13.5 B12.9 B9.3 B
Slightly volatile

Repligen Fundamental Market Drivers

Forward Price Earnings90.0901
Cash And Short Term Investments757.4 M

Repligen Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Repligen Financial Statements

Repligen investors utilize fundamental indicators, such as revenue or net income, to predict how Repligen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue15.2 M16 M
Total Revenue729.6 M766 M
Cost Of Revenue413.8 M234.1 M
Stock Based Compensation To Revenue 0.09  0.08 
Sales General And Administrative To Revenue 0.39  0.37 
Research And Ddevelopement To Revenue 0.08  0.07 
Capex To Revenue 0.06  0.10 
Revenue Per Share 10.21  10.72 
Ebit Per Revenue(0.05)(0.05)

Pair Trading with Repligen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repligen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Repligen Stock

  0.7TMO Thermo Fisher ScientificPairCorr
  0.62ILMN IlluminaPairCorr

Moving against Repligen Stock

  0.5300463 Maccura BiotechnologyPairCorr
  0.48TEM Tempus AI ClassPairCorr
  0.38PRTC PureTech Health plcPairCorr
The ability to find closely correlated positions to Repligen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repligen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repligen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repligen to buy it.
The correlation of Repligen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repligen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repligen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Repligen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:
Check out the analysis of Repligen Correlation against competitors.
To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.6
Earnings Share
0.02
Revenue Per Share
12.602
Quarterly Revenue Growth
0.219
Return On Assets
0.013
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.